Hippuric Acid

Hippuric Acid

SCHEMBL1179259

O=C(O)CNC(=O)c1ccccc1.[SrH2]

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TPH1TPH2

The experimentally established mechanism targets of Hippuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.66
▸ KDM4E B2RXH2 1/20 0.66
▸ HIF1A Q16665 1/20 0.66
▸ SLC22A6 Q4U2R8 1/20 0.66
▸ SLC22A8 Q8TCC7 1/20 0.66
▸ GAA P10253 1/20 0.65
▸ CA1 P00915 2/20 0.58
▸ CA2 P00918 1/20 0.58
▸ PTPRC P08575 2/20 0.56
▸ CTSL P07711 1/20 0.56
▸ PTPN13 Q12923 1/20 0.56
▸ ATM Q13315 1/20 0.54
▸ NPC1 O15118 4/20 0.53
▸ RAB9A P51151 4/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ LMNA P02545 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ GPR139 Q6DWJ6 1/20 0.53
▸ HDAC3 O15379 1/20 0.52
▸ CA12 O43570 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22030672 0.98 GAA (0.68) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL7486 0.98 GAA (0.68) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL428479 0.98 GAA (0.68) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL587978 0.96 MAPT (0.66) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL21569381 0.96 MAPT (0.66) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL11656206 0.96 MAPT (0.66) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL1458080 0.96 MAPT (0.66) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL7398337 0.96 MAPT (0.66) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL3448563 0.96 MAPT (0.66) MAPTKDM4EHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL7796688 0.96 KDM4E (0.66) MAPTKDM4EHIF1ASLC22A6SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3684740-B1 ALUMINA SINTERED BODY SHOWA DENKO KK (JP) 2021-07-28 — — EP disclosed
EP-3848340-A1 ABRASIVE GRAIN AND GRINDING WHEEL Showa Denko K.K. (JP) 2021-07-14 — — EP disclosed
US-11041102-B2 Alumina sintered body, abrasive grain, and grinding wheel SHOWA DENKO K.K. (JP) 2021-06-22 — — US disclosed
CN-111263740-B Alumina sintered body, abrasive grain, and grinding wheel 昭和电工株式会社 2021-06-11 — — CN disclosed
US-10941077-B2 Method for producing alumina sintered body SHOWA DENKO K.K. (JP) 2021-03-09 — — US disclosed
CN-111278947-B Method for producing alumina sintered body 昭和电工株式会社 2021-02-26 — — CN disclosed
EP-3673028-B1 METHOD FOR PRODUCING ALUMINA SINTERED BODY SHOWA DENKO KK (JP) 2021-02-10 — — EP disclosed
US-20200392044-A1 METHOD FOR PRODUCING ALUMINA SINTERED BODY SHOWA DENKO K.K. (JP) 2020-12-17 — — US disclosed
US-20200339849-A1 ALUMINA SINTERED BODY, ABRASIVE GRAIN, AND GRINDING WHEEL SHOWA DENKO K.K. (JP) 2020-10-29 — — US disclosed
CN-110382656-B Alumina sintered body, abrasive grain, and grinding wheel 昭和电工株式会社 2020-08-25 — — CN disclosed
CN-1981780-A Strontium compound for treatment of sub-dermal soft tissue pain SANTOSOLVE AS (NO) 2007-06-20 — — CN disclosed
US-20070053994-A1 Anti-inflammatory treatment SANA PHARMA MEDICAL AS (NO) 2007-03-08 — — US disclosed
EP-1741436-A1 Strontium compound for treatment of sub-dermal soft tissue pain Santosolve AS (NO) 2007-01-10 — — EP disclosed
CN-1795003-A Anti-inflammatory compositions based on strontium compounds SANTOSOLVE AS (NO) 2006-06-28 — — CN disclosed
EP-1605955-A2 ANTI-INFLAMMATORY COMPOSITION BASED ON STRONTIUM COMPOUNDS Santosolve AS (NO) 2005-12-21 — — EP disclosed
CN-1585646-A Strontium compounds for the treatment of subcutaneous soft tissue pain SANTOSOLVE AS (NO) 2005-02-23 — — CN disclosed
US-20050013877-A1 Strontium compound for treatment of sub-dermal soft tissue pain SANA PHARMA MEDICAL AS (NO) 2005-01-20 — — US disclosed
WO-2004084920-A2 ANTI-INFLAMMATORY TREATMENT BASED ON STRONTIUM COMPOUNDS SANTOSOLVE AS (NO) 2004-10-07 — — WO disclosed
EP-1429792-A1 STRONTIUM COMPOUND FOR TREATMENT OF SUB-DERMAL SOFT TISSUE PAIN Santosolve AS (NO) 2004-06-23 — — EP disclosed
WO-2003028742-A1 STRONTIUM COMPOUND FOR TREATMENT OF SUB-DERMAL SOFT TISSUE PAIN SANTOSOLVE AS (NO) 2003-04-10 — — WO disclosed
Send feedback